Postinjektionssyndrom efter behandling med olanzapin depot
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 281 KB, PDF document
Treatment with olanzapine depot is associated with a rare but potentially adverse reaction, namely post-injection delirium/sedation syndrome (PDSS), characterized by delirium and/or sedation. This is a case report of a 38-year-old male patient who developed symptoms consistent with PDSS shortly after receiving intramuscular injection of olanzapine depot. Clinicians should be aware of PDSS and observe patients for three hours after receiving the injection, measuring vitals and referring to medical care if necessary.
Translated title of the contribution | Post-injection delirium/sedation syndrome after treatment with olanzapine depot |
---|---|
Original language | Danish |
Article number | V02230069 |
Journal | Ugeskrift for Laeger |
Volume | 185 |
Issue number | 19 |
Number of pages | 4 |
ISSN | 0041-5782 |
Publication status | Published - 2023 |
Links
- https://ugeskriftet.dk/videnskab/postinjektionssyndrom-efter-behandling-med-olanzapin-depot
Final published version
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 346463893